The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing had its series of meetings to update breakpoints for a variety of classes of antimicrobials.
Morgan L. Bixby, PhD
Advertisement
Bixby is a current fellow with the Association of Public Health Laboratories/ Centers for Disease Control and Prevention following recent completion of her PhD in the Hirsch laboratory.
Articles by Morgan L. Bixby, PhD
This year's Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing provided updated breakpoints on therapies.
The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing held a virtual winter meeting and a hybrid summer meeting in 2022. Ad hoc working groups have several breakpoint revisions underway for multiple organism-drug combinations.
Advertisement
Latest Updated Articles
What’s New in 2022 From the CLSI Subcommittee on Antimicrobial Susceptibility TestingPublished: October 26th 2022 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Developing a COVID-19 Vaccine Alternative
2
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
3
Generic Lenacapavir Could Cost as Little as $25 Per Person Annually
4
Building Trust Through Vaccine Education and Science Communication
5
